Kiacta is used for the treatment of AA Amyloidosis developed by Neurochem, which received approval from the US Food and Drugs Administration (FDA).
In its approval the FDA requested additional efficacy information, as well as a safety update. The FDA stated that this efficacy information would most likely need to be addressed by one or more additional clinical trials. As an alternative, the FDA also stated that significant findings obtained from a complete follow-up of patients ...
| Currently you cannot purchase Keacta as it might be not available for sale online or on local pharmacy. Subscribe below and we will inform you where and when you can order Keacta |
| Keacta Availability Subscription Form |
|
| |
| Note: We will email you when Keacta is available for sale online or in pharmacy in your country. |
|
|
|
